Intravitreal Bevacizumab

PreclinicalMonoclonal antibody

AAsociación para Evitar la Ceguera en México

Intravitreal Bevacizumab is one of 56 small molecule programs targeting Hemorrhage. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

HemorrhageActive, not recruiting

Polypoidal Choroidal VasculopathyActive, not recruiting

HemorrhagePreclinical

Active, not recruiting

Polypoidal Choroidal VasculopathyPreclinical

Active, not recruiting

Competition

Competitive Landscape

61 competitors in Hemorrhage

#DrugCompanyPhaseTrials

Plavix

Klor-Con

Bayer Aspirin

Eliquis

Prevacid

Savaysa

Ketalar

1 8

Decadron

AAspen Global Incorporated

Approved

1 9

Coumadin

AAbbott

Approved

1 10

Adrenaline

SSamson Clinical Operations Pty Ltd

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Diabetic Macular Edema8 trials

Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema

Completed·AAsociación para Evitar la Ceguera en México·Phase 4·NCT05736081·15 enrolled

Effect of Dexamethasone Implant in Hard Exudate Complicated With Diabetic Macular Edema

Unknown status·IInje University·Phase 4·NCT02399657·48 enrolled

Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema

Completed·TTehran University of Medical Sciences·Phase 2·NCT02663141·57 enrolled

Show 5 more trials

Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema

Terminated·—·Phase 4·NCT04991350·5 enrolled

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Completed·RRetina Macula Institute·Phase 2·NCT01571232·20 enrolled

Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

Withdrawn·AAsociación para Evitar la Ceguera en México·Phase 3·NCT00417716

Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study

Completed·UUniversity of Sao Paulo·Phase 3·NCT02308644·41 enrolled

Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)

Completed·UUniversity of Sao Paulo·Phase 3·NCT00997191·12 enrolled

Proliferative Diabetic Retinopathy2 trials

Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy

Completed·AAnders Kvanta·Phase 2·NCT01478737·100 enrolled

Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy

Completed·JJ. Fernando Arevalo, MD FACS·Phase 3·NCT01976923·224 enrolled

Unknown status·UUniversity of Malaya·N/A·NCT01626339·30 enrolled

5 more indications

Hemorrhage1 trial

Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular Proliferation

Unknown status·NNational Taiwan University Hospital·N/A·NCT00673296·6 enrolled

Bevacizumab1 trial

Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment

Terminated·AAsociación para Evitar la Ceguera en México·Phase 2/3·NCT00417833

Retinopathy of Prematurity1 trial

A Dosing Study of Intravitreal Bevacizumab for Retinopathy of Prematurity

Completed·—·Phase 3·NCT05712642·19 enrolled

Macular Degeneration1 trial

Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial

Unknown status·SShahid Beheshti University of Medical Sciences·Phase 2/3·NCT03609307·40 enrolled

Polypoidal choroidal vasculopathy1 trial

Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy

Unknown status·—·N/A·NCT00383812·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 18 trial records for Intravitreal Bevacizumab. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Intravitreal Bevacizumab compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Intravitreal Bevacizumab. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Asociación para Evitar la Ceguera en México company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Monoclonal antibody[2]
Highest Phase: Preclinical[1]
Company: AAsociación para Evitar la Ceguera en México

Intravitreal Bevacizumab

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Diabetic Macular Edema8 trials

Proliferative Diabetic Retinopathy2 trials

Diabetic Retinopathy1 trial

Choroidal Neovascularization1 trial

ESS1 trial

Hemorrhage1 trial

Bevacizumab1 trial

Retinopathy of Prematurity1 trial

Macular Degeneration1 trial

Polypoidal choroidal vasculopathy1 trial

References

Drug Info

Quick Facts

Related News